Enhanced and Extended Anti-Hypertensive Effect of VP5 Nanoparticles
AbstractHypertension has become a significant global public health concern and is also one of the most common risk factors of cardiovascular disease. Recent studies have shown the promising result of peptides inhibiting angiotensin converting enzyme (ACE) in lowering the blood pressure in both animal models and humans. However, the oral bioavailability and continuous antihypertensive effectiveness require further optimization. Novel nanoparticle-based drug delivery systems are helpful to overcome these barriers. Therefore, a poly-(lactic-co-glycolic) acid nanoparticle (PLGANPs) oral delivery system, of the antihypertensive small peptides Val-Leu-Pro-Val-Pro (VLPVP, VP5) model, was developed in this study and its antihypertensive effect was investigated in spontaneously hypertensive rats (SHRs) for the first time. The obtained VP5 nanoparticles (VP5-NPs) showed a small particle size of 223.7 ± 2.3 nm and high entrapment efficiency (EE%) of 87.37% ± 0.92%. Transmission electronic microscopy (TEM) analysis showed that the nanoparticles were spherical and homogeneous. The optimal preparation of VP5-NPs exhibited sustained release of VP5 in vitro and a 96 h long-term antihypertensive effect with enhanced efficacy in vivo. This study illustrated that PLGANPs might be an optimal formulation for oral delivery of antihypertensive small peptides and VP5-NPs might be worthy of further development and use as a potential therapeutic strategy for hypertension in the future. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Yu, T.; Zhao, S.; Li, Z.; Wang, Y.; Xu, B.; Fang, D.; Wang, F.; Zhang, Z.; He, L.; Song, X.; Yang, J. Enhanced and Extended Anti-Hypertensive Effect of VP5 Nanoparticles. Int. J. Mol. Sci. 2016, 17, 1977.
Yu T, Zhao S, Li Z, Wang Y, Xu B, Fang D, Wang F, Zhang Z, He L, Song X, Yang J. Enhanced and Extended Anti-Hypertensive Effect of VP5 Nanoparticles. International Journal of Molecular Sciences. 2016; 17(12):1977.Chicago/Turabian Style
Yu, Ting; Zhao, Shengnan; Li, Ziqiang; Wang, Yi; Xu, Bei; Fang, Dailong; Wang, Fazhan; Zhang, Zhi; He, Lili; Song, Xiangrong; Yang, Jian. 2016. "Enhanced and Extended Anti-Hypertensive Effect of VP5 Nanoparticles." Int. J. Mol. Sci. 17, no. 12: 1977.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.